• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.12% Nasdaq Down 0.60%

    More On ALPMY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Astellas Pharma, Inc. (ALPMY)

    -Other OTC
    15.43 Up 0.21(1.38%) 10:49AM EST
    Add to Portfolio
    Prev Close:15.22
    Open:15.38
    Bid:N/A
    Ask:N/A
    1y Target Est:50.00
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:15.38 - 15.43
    52wk Range:10.63 - 15.77
    Volume:5,388
    Avg Vol (3m):28,850
    Market Cap:N/A
    P/E (ttm):35.80
    EPS (ttm):0.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Astellas Pharma Inc. manufactures, markets, and imports/exports pharmaceutical products worldwide. The company focuses on the therapeutic areas of urology, immunology and infectious diseases, oncology, neuroscience, and diabetes mellitus complicat... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback